Copyright 2002 American Medical Association. All Rights Reserved.
Applicable FARS/DFARS Restrictions Apply to Government Use.2002
Chepeha DB, Yoo J, Birt C, Gilbert RW, Chen J
Arch Otolaryngol Head Neck Surg. 2001;127:299-303
Objectives: To assess which signs and symptoms were relieved by gold weight implantation
and which signs and symptoms persisted.
Design: Prospective observational cohort.
Setting: Tertiary care neurotology and oncology center.
Patients: Sixteen (4 males and 12 females) consecutive patients whose average
age was 56 years (age range, 31-76 years). Inclusion criteria were gold weight
implant, lagophthalmus of 2 mm or more, and a House-Brackmann score of 3 or
less at the completion of follow-up. Mean follow-up was 13 months.
May M. Prospective Evaluation of Eyelid Function With Gold Weight Implant and Lower Eyelid Shortening for Facial Paralysis. Arch Facial Plast Surg. 2002;4(1):60-61. doi: